It will be interesting to see why 6 month sales on
Post# of 36568
(Total Views: 361)
Posted On: 03/25/2019 11:24:27 AM
It will be interesting to see why 6 month sales on 6/30/18 dropped dramatically from the 6 months 12/31/17.
VENETO HOLDINGS, LLC
CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE SIX MONTHS ENDED JUNE 30, 2018 AND 2017
Dollars in thousands
2018 2017
REVENUE, NET $ 25,773 $ 58,993
COST OF GOODS SOLD 14,427 31,575
GROSS PROFIT 11,346 27,418
SELLING, GENERAL, AND ADMINISTRATIVE EXPENSES 17,853 19,182
OPERATING INCOME (LOSS) (6,507 ) 8,236
INTEREST EXPENSE, NET 235 140
OTHER EXPENSE (INCOME), NET (546 ) 159
NET INCOME (LOSS) (6,196 ) 7,937
LESS NET INCOME ATTRIBUTABLE TO NONCONTROLLING INTERESTS 2,401 4,544
NET INCOME (LOSS) ATTRIBUTABLE TO VENETO HOLDINGS, LLC $ (8,597 ) $ 3,393
The accompanying notes are an integral part of these consolidated financial statements.
VENETO HOLDINGS, LLC
CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE SIX MONTHS ENDED JUNE 30, 2018 AND 2017
Dollars in thousands
2018 2017
REVENUE, NET $ 25,773 $ 58,993
COST OF GOODS SOLD 14,427 31,575
GROSS PROFIT 11,346 27,418
SELLING, GENERAL, AND ADMINISTRATIVE EXPENSES 17,853 19,182
OPERATING INCOME (LOSS) (6,507 ) 8,236
INTEREST EXPENSE, NET 235 140
OTHER EXPENSE (INCOME), NET (546 ) 159
NET INCOME (LOSS) (6,196 ) 7,937
LESS NET INCOME ATTRIBUTABLE TO NONCONTROLLING INTERESTS 2,401 4,544
NET INCOME (LOSS) ATTRIBUTABLE TO VENETO HOLDINGS, LLC $ (8,597 ) $ 3,393
The accompanying notes are an integral part of these consolidated financial statements.
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Disclaimer: Of course, all of this is my opinion and you should not make any investment decisions based on my opinion. I have not received any non-public information.